Taiyo Pharmaceutical Co Ltd
⚠️ Moderate Risk
FEI: 3003807704 • Takayama, Gifu • JAPAN
FEI Number
3003807704
Location
Takayama, Gifu
Country
JAPANAddress
1040-22, Matsunoki-Machi, Takayama, Gifu, Japan
Moderate Risk
FDA Import Risk Assessment
This firm has a moderate history of FDA import refusals. Some attention may be warranted.
Statistics
Score Breakdown
How is this score calculated?
Proprietary Algorithm
- 40% Violation Severity — AI-assessed (1-10)
- 30% Refusal Volume — Logarithmic scale
- 20% Recency — Decays over 5 years
- 10% Frequency — Refusals per year
© ImportRefusal.com Original Analysis
Violation Summary
UNAPPROVED
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).
Refusal History
Frequently Asked Questions
What is Taiyo Pharmaceutical Co Ltd's FDA import refusal history?
Taiyo Pharmaceutical Co Ltd (FEI: 3003807704) has 2 FDA import refusal record(s) in our database, spanning from 10/23/2002 to 11/27/2002.
What is an FEI number?
FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Taiyo Pharmaceutical Co Ltd's FEI number is 3003807704.
What types of violations has Taiyo Pharmaceutical Co Ltd received?
Taiyo Pharmaceutical Co Ltd has been cited for 1 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.
Where does this information about Taiyo Pharmaceutical Co Ltd come from?
All FDA import refusal data for Taiyo Pharmaceutical Co Ltd is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.
Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.